Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fulgent Genetics, Inc.FLGT · Entity 2545 | Director | May 18, 2022 | May 20, 2022 |
| NOMAD POWER SOLUTIONS, INC.LIXT · Entity 6975 | Director | June 30, 2025 | July 09, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fulgent Genetics, Inc.
Report date May 18, 2022 · Filed May 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,000 |
Reported balance
After 2022-05-18 transaction · row 1
1 source rowRow 1 · 2022-05-18 · Grant · Acquired 2,000 · Balance 2,000 F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
NOMAD POWER SOLUTIONS, INC.
Report date June 30, 2025 · Filed July 09, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.91 · Expires 2030-06-30 | Direct | 10,000 |
Reported balance
After 2025-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-30 · Grant · Acquired 10,000 · Balance 10,000 F1: Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025. |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.91 · Expires 2030-06-30 | Direct | 11,632 |
Reported balance
After 2025-06-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-30 · Grant · Acquired 11,632 · Balance 11,632 F2: Effective June 30, 2025 the reporting person was granted stock options in aggregate of 11,632 vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan. |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.21 · Expires 2030-03-31 | Direct | 8,777 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 8,777 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.33 · Expires 2030-01-20 | Direct | 4,545 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 4,545 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2029-09-30 | Direct | 5,786 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 5,786 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.37 · Expires 2029-06-30 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,000 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.37 · Expires 2029-06-30 | Direct | 4,527 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 4,527 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $7.45 · Expires 2027-06-30 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,000 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $30.30 · Expires 2026-06-30 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 10,000 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $32.10 · Expires 2026-01-06 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 5,000 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $16.80 · Expires 2023-08-04 | Direct | 3,333 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 3,333 |
| Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $66.00 · Expires 2024-05-22 | Direct | 833 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 833 |
| Warrants to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $57.00 · Expires 2025-11-30 | IndirectBy Sino-American Cancer FDD | 5,263 |
Reported balance
Holding disclosure · report date 2025-06-30 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 5,263 |
Filing footnotes · ownership attribution and instrument terms
F1: Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025.
F2: Effective June 30, 2025 the reporting person was granted stock options in aggregate of 11,632 vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2025 Filed Jul 9, 2025 11:52 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 11,632 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001641172-25-018338 · ownership.xml · derivative · entry 2 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,632 Underlying: Common · 11,652 shares Expires 2030-06-30 F2 · price: Effective June 30, 2025 the reporting person was granted stock options in aggregate of 11,632 vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan. Read SEC document |
| June 30, 2025 Filed Jul 9, 2025 11:52 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001641172-25-018338 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common · 10,000 shares Expires 2030-06-30 F1 · price: Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 10:36 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 8,777 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001641172-25-002302 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,777 Underlying: Common · 8,777 shares Expires 2030-03-31 F1 · price: Effective March 31, 2025, the reporting person was granted stock options to purchase an aggregate of 8,777 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan. Read SEC document |
| January 20, 2025 Filed Jan 22, 2025 13:20 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 4,545 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0001493152-25-003187 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,545 Underlying: Common · 4,545 shares Expires 2030-01-20 F1 · price: Effective January 20, 2025, the reporting person was granted stock options to purchase an aggregate of 4,545 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan. Read SEC document |
| September 30, 2024 Filed Oct 29, 2024 17:42 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 5,786 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001493152-24-042954 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,786 Underlying: Common · 5,786 shares Expires 2029-09-30 F1 · price: Effective September 30, 2024, the reporting person was granted stock options to purchase an aggregate of 5,786 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 18:27 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 4,527 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-24-026075 · ownership.xml · derivative · entry 2 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,527 Underlying: Common · 4,527 shares Expires 2029-06-30 F2 · price: Effective June 30, 2024, the reporting person was granted stock options to purchase an aggregate of 4,527 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the Reporting Person under the Board Compensation Plan. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 18:27 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-24-026075 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common · 10,000 shares Expires 2029-06-30 F1 · price: Effective June 30, 2024, the reporting person was granted stock options to purchase an aggregate of 10,000 shares, vesting on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 30, 2024). Read SEC document |
| June 30, 2023 Filed Jul 7, 2023 10:58 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001493152-23-023930 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common · 10,000 shares Expires 2028-06-30 F1 · price: Effective June 30, 2023, the reporting person was granted stock options to purchase an aggregate of 10,000 shares, vesting on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 30, 2023). Effective June 2, 2023, the Issuer effected a 1-for-10 reverse split of its outstanding shares of common stock. Accordingly, the exercise price and the amount of underlying shares of Common Stock set forth above have been adjusted to reflect the reverse split. Read SEC document |
| June 30, 2022 Filed Aug 3, 2022 16:47 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001493152-22-021184 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common · 100,000 shares Expires 2027-06-30 F1 · price: Effective June 30, 2022, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 30, 2022). Read SEC document |
| May 18, 2022 Filed May 20, 2022 16:06 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030968 · doc4.xml · nonDerivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 16:06 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001493152-21-016038 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common · 100,000 shares Expires 2026-06-30 F1 · price: Effective June 30, 2021, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting in eight equal installments on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 20, 2021). Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:29 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $73.64 | $0.00 |
DisclosureSEC source: 0001209191-21-035457 · doc4.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2031-05-19 F1 · derivative.exercise_date: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 20, 2021, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. Read SEC document |
| January 06, 2021 Filed Jan 14, 2021 14:34 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | GrantOptions to Purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001493152-21-001041 · ownership.xml · derivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common · 50,000 shares Expires 2026-01-06 Read SEC document |
| November 30, 2020 Filed Dec 4, 2020 16:55 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | PurchaseWarrants to Purchase Common Stock · Derivative | 52,632 | $4.75 Strike: $5.70 | $250,002.00 |
DisclosureSEC source: 0001493152-20-022975 · ownership.xml · derivative · entry 2 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Sino-American Cancer FDD Disclosed balance after: 52,632 Underlying: Common · 52,632 shares Expires 2025-11-30 F1 · price: The reporting person acquired 52,632 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit. Read SEC document |
| November 30, 2020 Filed Dec 4, 2020 16:55 UTC | NOMAD POWER SOLUTIONS, INC. LIXT · Entity 6975 | PurchaseCommon Stock | 52,632 | $4.75 | $250,002.00 |
DisclosureSEC source: 0001493152-20-022975 · ownership.xml · nonDerivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Sino-American Cancer FDD Disclosed balance after: 52,632 F1 · price: The reporting person acquired 52,632 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit. Read SEC document |
| May 27, 2020 Filed May 27, 2020 21:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | OtherCommon Stock | 526,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032493 · doc4.xml · nonDerivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transfer was made without the receipt of consideration to a blind trust. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16 or for any other purpose. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantIssuer Common Stock | 526,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144613 · doc4.xml · nonDerivative · entry 2 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,315 F3 · price: The securities were received in the Reorganization in exchange for the cancellation of 4,000,000 of the Predecessor's Class D voting common units. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Disposition to issuerPredecessor Class D Voting Common Units | 4,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144613 · doc4.xml · nonDerivative · entry 1 Yen Yun · CIK 0001684584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Reflects securities of Fulgent Therapeutics LLC (the "Predecessor" or "Fulgent LLC"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the "Issuer") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the "Reorganization"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D voting common units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1. F2 · price: The securities were disposed of and cancelled in the Reorganization in exchange for 526,315 shares of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.